SCHEMBL4441972

SCHEMBL4441972

COc1ccccc1N1CCN(CCCCOc2cccc3ccnn23)CC1.Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl.Clc1ccccc1N1CCN(CCCCOc2cccc3ccnn23)CC1

nearest known ligand 0.83

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.83
DRD3 P35462 10/20 0.83
DRD4 P21917 9/20 0.83
HTR2A P28223 6/20 0.57
DRD1 P21728 3/20 0.57
HTR1A P08908 5/20 0.56
ADRA1D P25100 1/20 0.56
HTR2C P28335 1/20 0.56
ADRA1A P35348 1/20 0.56
ADRA1B P35368 1/20 0.56
HTR2B P41595 1/20 0.56
KCNH2 Q12809 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3608995 0.92 DRD2 (0.70) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3610324 0.91 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3608700 0.89 DRD3 (0.88) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4445019 0.75 DRD3 (0.60) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4564124 0.73 DRD2 (0.60) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4443269 0.73 DRD2 (0.76) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3605911 0.73 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3614783 0.73 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL3615525 0.73 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL4450992 0.73 ALDH1A1 (0.57) DRD2DRD3DRD4HTR2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137185-A2 INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS Gmeiner, Dr. Peter (DE) 2009-12-30 EP claimed
WO-2008113559-A2 INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS SCHWARZ PHARMA AG (DE) 2008-09-25 WO claimed